Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsored by: |
Centro Cardiologico Monzino |
---|---|
Information provided by: | Centro Cardiologico Monzino |
ClinicalTrials.gov Identifier: | NCT00517426 |
To evaluate the effects of CO2 inhalation and acetazolamide treatment on exercise-induced periodic breathing in patients with chronic stable heart failure.
Patients will be given CO2 (2%) during a constant workload exercise. Patients will be also evaluated by maximal cardiopulmonary exercise test without and with acetazolamide acute and chronic treatment.
Condition | Intervention | Phase |
---|---|---|
Chronic Heart Failure |
Drug: acetazolamide |
Phase IV |
Study Type: | Interventional |
Study Design: | Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study |
Estimated Enrollment: | 20 |
Study Start Date: | July 2007 |
Estimated Study Completion Date: | August 2009 |
Ages Eligible for Study: | 18 Years to 80 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Piergiuseppe Agostoni, MD, PhD | +39.025800 ext 2299 | piergiuseppe.agostoni@ccfm.it |
Italy | |
Centro Cardiologico Monzino, University of Milan | Recruiting |
Milan, Italy, 20138 | |
Contact: Piergiuseppe Agostoni, MD, PhD +39.025800 ext 2299 piergiuseppe.agostoni@ccfm.it | |
Sub-Investigator: Mauro Contini, MD |
Principal Investigator: | Piergiuseppe Agostoni, MD, PhD | Centro Cardiologico Monzino |
Study ID Numbers: | R77-CCM S79/407 |
Study First Received: | August 16, 2007 |
Last Updated: | August 16, 2007 |
ClinicalTrials.gov Identifier: | NCT00517426 |
Health Authority: | Italy: Ministry of Health |
heart failure, exercise periodic breathing, acetazolamide |
Heart Failure Heart Diseases Acetazolamide |
Carbonic Anhydrase Inhibitors Molecular Mechanisms of Pharmacological Action Natriuretic Agents Therapeutic Uses Physiological Effects of Drugs Diuretics |
Enzyme Inhibitors Cardiovascular Diseases Cardiovascular Agents Central Nervous System Agents Pharmacologic Actions Anticonvulsants |